Synopsis
Synopsis
0
USDMF
0
JDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 10034-99-8
2. Epsom Salt
3. Magnesium Sulphate Heptahydrate
4. Magnesium Sulfate (1:1) Heptahydrate
5. Magnesia Sulphurica
6. Mfcd00149785
7. Magnesium;sulfate;heptahydrate
8. Epsom Salt(heptahydrate)
9. Sulfuric Acid Magnesium Salt (1:1), Heptahydrate
10. Magnesiumsulfateheptahydrate
11. Sk47b8698t
12. Sulfuric Acid Magnesium Salt Heptahydrate
13. Epsomite
14. Magnesium Sulfate [usan:jan]
15. Mgso4*7h2o
16. Mgso4.7h2o
17. Magnesium Sufate Heptahydrate
18. Bittersalz
19. Unii-sk47b8698t
20. Epsomite (mg(so4).7h20)
21. Magnesium Sulfate Heptahydrate (mgso4.7h2o)
22. Sulfuric Acid, Magnesium Salt, Hydrate (1:1:7)
23. Sulfuric Acid, Magnesium Salt (1:1), Heptahydrate
24. Conclyte-mg (tn)
25. Magnesium Sulfate (usp)
26. Magnesium(ii), Sulfate, Heptahydrate
27. Magnesii Sulfatis Heptahydras
28. Magnesium Sulphate 7-hydrate
29. Epsom Salt [who-ip]
30. Chembl3989857
31. Dtxsid5040544
32. Chebi:31795
33. Magnesium Sulfate--water (1/7)
34. Magnesia Sulphurica [hpus]
35. Magnesium Sulfate Hydrate (jp17)
36. Akos015903838
37. Magnesium Sulfate Hydrate [jan]
38. 14457-55-7
39. Magnesium Sulfate Heptahydrate [mi]
40. Ft-0628096
41. E-518(magnesium Sulfate Heptahydrate)
42. Magnesium Sulphate (1:1) Heptahydrate
43. D01108
44. Magnesium Sulfate Heptahydrate [who-dd]
45. Ins-518(magnesium Sulfate Heptahydrate)
46. Ins No.518(magnesium Sulfate Heptahydrate)
47. Magnesii Sulfatis Heptahydras [who-ip Latin]
48. Magnesium Sulfate Heptahydrate [ep Impurity]
49. Magnesium Sulfate Heptahydrate [ep Monograph]
50. Magnesium Sulfate Heptahydrate, Cell Culture Reagent
51. Magnesium Sulfate Heptahydrate [usp Monograph]
52. Q15628528
Molecular Weight | 246.48 g/mol |
---|---|
Molecular Formula | H14MgO11S |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 0 |
Exact Mass | 246.0107241 g/mol |
Monoisotopic Mass | 246.0107241 g/mol |
Topological Polar Surface Area | 95.6 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 62.2 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 9 |
MAGNESIUM SULFATE HEPTAHYDRATE
NDC Package Code : 67706-0013
Start Marketing Date : 2015-02-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
MAGNESIUM SULFATE HEPTAHYDRATE
NDC Package Code : 10695-019
Start Marketing Date : 2017-03-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
MAGNESIUM SULFATE HEPTAHYDRATE
NDC Package Code : 10695-019
Start Marketing Date : 2016-09-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
A Magnesium Sulfate Heptahydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Magnesium Sulfate Heptahydrate, including repackagers and relabelers. The FDA regulates Magnesium Sulfate Heptahydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Magnesium Sulfate Heptahydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Magnesium Sulfate Heptahydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Magnesium Sulfate Heptahydrate supplier is an individual or a company that provides Magnesium Sulfate Heptahydrate active pharmaceutical ingredient (API) or Magnesium Sulfate Heptahydrate finished formulations upon request. The Magnesium Sulfate Heptahydrate suppliers may include Magnesium Sulfate Heptahydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Magnesium Sulfate Heptahydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Magnesium Sulfate Heptahydrate Drug Master File in Korea (Magnesium Sulfate Heptahydrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Magnesium Sulfate Heptahydrate. The MFDS reviews the Magnesium Sulfate Heptahydrate KDMF as part of the drug registration process and uses the information provided in the Magnesium Sulfate Heptahydrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Magnesium Sulfate Heptahydrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Magnesium Sulfate Heptahydrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Magnesium Sulfate Heptahydrate suppliers with KDMF on PharmaCompass.
A Magnesium Sulfate Heptahydrate CEP of the European Pharmacopoeia monograph is often referred to as a Magnesium Sulfate Heptahydrate Certificate of Suitability (COS). The purpose of a Magnesium Sulfate Heptahydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Magnesium Sulfate Heptahydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Magnesium Sulfate Heptahydrate to their clients by showing that a Magnesium Sulfate Heptahydrate CEP has been issued for it. The manufacturer submits a Magnesium Sulfate Heptahydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Magnesium Sulfate Heptahydrate CEP holder for the record. Additionally, the data presented in the Magnesium Sulfate Heptahydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Magnesium Sulfate Heptahydrate DMF.
A Magnesium Sulfate Heptahydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Magnesium Sulfate Heptahydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Magnesium Sulfate Heptahydrate suppliers with CEP (COS) on PharmaCompass.
A Magnesium Sulfate Heptahydrate written confirmation (Magnesium Sulfate Heptahydrate WC) is an official document issued by a regulatory agency to a Magnesium Sulfate Heptahydrate manufacturer, verifying that the manufacturing facility of a Magnesium Sulfate Heptahydrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Magnesium Sulfate Heptahydrate APIs or Magnesium Sulfate Heptahydrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Magnesium Sulfate Heptahydrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Magnesium Sulfate Heptahydrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Magnesium Sulfate Heptahydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Magnesium Sulfate Heptahydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Magnesium Sulfate Heptahydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Magnesium Sulfate Heptahydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Magnesium Sulfate Heptahydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Magnesium Sulfate Heptahydrate suppliers with NDC on PharmaCompass.
Magnesium Sulfate Heptahydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Magnesium Sulfate Heptahydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Magnesium Sulfate Heptahydrate GMP manufacturer or Magnesium Sulfate Heptahydrate GMP API supplier for your needs.
A Magnesium Sulfate Heptahydrate CoA (Certificate of Analysis) is a formal document that attests to Magnesium Sulfate Heptahydrate's compliance with Magnesium Sulfate Heptahydrate specifications and serves as a tool for batch-level quality control.
Magnesium Sulfate Heptahydrate CoA mostly includes findings from lab analyses of a specific batch. For each Magnesium Sulfate Heptahydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Magnesium Sulfate Heptahydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Magnesium Sulfate Heptahydrate EP), Magnesium Sulfate Heptahydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Magnesium Sulfate Heptahydrate USP).
LOOKING FOR A SUPPLIER?